Biogen's Alzheimer's drug gets negative European panel vote
By Manas MishraNov 17 (Reuters) - A European regulatory panel voted against approval of Biogen Inc's Alzheimer's disease drug, in a possible blow to the...
By Manas MishraNov 17 (Reuters) - A European regulatory panel voted against approval of Biogen Inc's Alzheimer's disease drug, in a possible blow to the...